TABLE 3.
Statin use among patients treated with non‐statin LLT
| Patients with non‐statin LLT overall N = 1930 | Patients treated with fish oil N = 1249 | Patients treated with fibrate N = 417 | Patients treated with ezetimibe N = 329 | Patients treated with niacin N = 196 | |
|---|---|---|---|---|---|
| Statin (overall) at visit | 73.7% | 71.7% | 74.8% | 79.9% | 82.1% |
| High intensity a | 32.1% | 31.8% | 36.9% | 34.4% | 35.4% |
| Moderate intensity a | 57.9% | 57.7% | 55.0% | 54.8% | 60.9% |
| Low intensity a | 10.0% | 10.5% | 8.1% | 10.8% | 3.7% |
| Lower than guideline‐recommended statin dose | 45.4% | 44.4% | 46.7% | 47.4% | 40.0% |
a
Among patients with a statin at the visit.